Correlation of Mild Cognitive Impairment with the Thickness of Retinal Nerve Fiber Layer and Serum Indicators in Type 2 Diabetic Patients

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Jan 23

PMID 38260156

Authors

Renshi Li

Fengjie Zheng

Peichen Xu

Li Lv

Yapeng Mu

Xianghua Zhuang

Shihong Chen

Affiliations

Soon will be listed here.

Abstract

Background: Cognitive Impairment arising from type 2 diabetes mellitus (T2DM) has garnered significant attention in recent times. However, there are few studies on the identification and diagnosis of markers of cognitive impairment. Notably, alterations in the Retinal Nerve Fiber Layer's (RNFL) thickness can potentially serve as an indicative measure of central nervous system changes. Further investigations have indicated that the decline in cognitive function within T2DM patients is intricately linked to persistent systemic inflammation and the accumulation of advanced glycosylation end products. Comprehensive studies are warranted to unveil these complex associations.

Objective: This study aims to explore the potential of utilizing the RNFL thickness and serological concentrations of IL-18, irisin, CML, and RAGE as diagnostic indicators for Mild Cognitive Impairment (MCI) among individuals with T2DM.

Methods: The thickness of RNFL were determined in all patients and controls using optical coherence tomography (OCT). The serum levels of IL-18, irisin, CML and RAGE were detected by ELISA kit. In addition, Cognitive assessment was performed by the Mini-Mental State Examination (MMSE) and the Montreal Cognitive assessment (MoCA).

Results: The average RNFL thickness in the right eye were decreased in T2DM and T2DM combined with MCI (T2DM-MCI) patients and were positively correlated with MoCA and MMSE scores. The serum levels of IL-18, CML and RAGE in T2DM and T2DM-MCI increased significantly (p<0.05) and were negative correlated with MoCA and MMSE scores. The level of irisin in T2DM and T2DM-MCI decreased significantly (p<0.05) and were positively correlated with MoCA and MMSE scores. The area under the ROC curve of T2DM-MCI predicted by the average RNFL thickness in the right eye, CML and RAGE were 0.853, 0.874 and 0.815. The diagnostic efficacy of the combination of average RNFL thickness in the right eye, CML, and RAGE for the diagnosis of T2DM-MCI was 0.969.

Conclusion: The average RNFL thickness in the right eye, CML and RAGE have possible diagnostic value in T2DM-MCI patients.

References

Karvani M, Simos P, Stavrakaki S, Kapoukranidou D . Neurocognitive impairment in type 2 diabetes mellitus. Hormones (Athens). 2019; 18(4):523-534. DOI: 10.1007/s42000-019-00128-2. View

Cole J, Florez J . Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020; 16(7):377-390. PMC: 9639302. DOI: 10.1038/s41581-020-0278-5. View

Lourenco M, Frozza R, de Freitas G, Zhang H, Kincheski G, Ribeiro F . Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models. Nat Med. 2019; 25(1):165-175. PMC: 6327967. DOI: 10.1038/s41591-018-0275-4. View

Rojas M, Chavez-Castillo M, Bautista J, Ortega A, Nava M, Salazar J . Alzheimer's disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links. World J Diabetes. 2021; 12(6):745-766. PMC: 8192246. DOI: 10.4239/wjd.v12.i6.745. View

Zhao A, Fang F, Li B, Chen Y, Qiu Y, Wu Y . Visual Abnormalities Associate With Hippocampus in Mild Cognitive Impairment and Early Alzheimer's Disease. Front Aging Neurosci. 2021; 12:597491. PMC: 7862343. DOI: 10.3389/fnagi.2020.597491. View

Polyzos S, Anastasilakis A, Efstathiadou Z, Makras P, Perakakis N, Kountouras J . Irisin in metabolic diseases. Endocrine. 2017; 59(2):260-274. DOI: 10.1007/s12020-017-1476-1. View

Shi R, Lu Y, Liu D, Guo Z . Association of serum apolipoprotein B with retinal neurovascular structural alterations in patients with type 2 diabetes: an optical coherence tomography angiography study. Acta Diabetol. 2021; 58(12):1673-1681. DOI: 10.1007/s00592-021-01775-x. View

Indyk D, Bronowicka-Szydelko A, Gamian A, Kuzan A . Advanced glycation end products and their receptors in serum of patients with type 2 diabetes. Sci Rep. 2021; 11(1):13264. PMC: 8225908. DOI: 10.1038/s41598-021-92630-0. View

Choi J, Kim H, Kwon J, Shim Y, Jee D, Yun J . Early inner retinal thinning and cardiovascular autonomic dysfunction in type 2 diabetes. PLoS One. 2017; 12(3):e0174377. PMC: 5363937. DOI: 10.1371/journal.pone.0174377. View

10.

Zhang F, Hou G, Hou G, Wang C, Shi B, Zheng Y . Serum Irisin as a Potential Biomarker for Cognitive Decline in Vascular Dementia. Front Neurol. 2021; 12:755046. PMC: 8473826. DOI: 10.3389/fneur.2021.755046. View

11.

Ruiz H, Ramasamy R, Schmidt A . Advanced Glycation End Products: Building on the Concept of the "Common Soil" in Metabolic Disease. Endocrinology. 2019; 161(1). PMC: 7188081. DOI: 10.1210/endocr/bqz006. View

12.

Chan V, Sun Z, Tang S, Chen L, Wong A, Tham C . Spectral-Domain OCT Measurements in Alzheimer's Disease: A Systematic Review and Meta-analysis. Ophthalmology. 2018; 126(4):497-510. PMC: 6424641. DOI: 10.1016/j.ophtha.2018.08.009. View

13.

Santangelo R, Huang S, Bernasconi M, Falautano M, Comi G, Magnani G . Neuro-Retina Might Reflect Alzheimer's Disease Stage. J Alzheimers Dis. 2020; 77(4):1455-1468. DOI: 10.3233/JAD-200043. View

14.

Liu D, Zhang L, Li Z, Zhang X, Wu Y, Yang H . Thinner changes of the retinal nerve fiber layer in patients with mild cognitive impairment and Alzheimer's disease. BMC Neurol. 2015; 15:14. PMC: 4342899. DOI: 10.1186/s12883-015-0268-6. View

15.

Sathyapalan T, Atkin S . Is there a role for immune and anti-in-flammatory therapy in type 2 diabetes?. Minerva Endocrinol. 2011; 36(2):147-56. View

16.

Villegas-Rodriguez M, Uribarri J, Solorio-Meza S, Fajardo-Araujo M, Cai W, Torres-Graciano S . The AGE-RAGE Axis and Its Relationship to Markers of Cardiovascular Disease in Newly Diagnosed Diabetic Patients. PLoS One. 2016; 11(7):e0159175. PMC: 4951143. DOI: 10.1371/journal.pone.0159175. View

17.

Luft V, Duncan B, Schmidt M, Chambless L, Pankow J, Hoogeveen R . Carboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study. Diabet Med. 2015; 33(10):1392-8. PMC: 4929039. DOI: 10.1111/dme.12963. View

18.

Ojala J, Alafuzoff I, Herukka S, van Groen T, Tanila H, Pirttila T . Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients. Neurobiol Aging. 2007; 30(2):198-209. DOI: 10.1016/j.neurobiolaging.2007.06.006. View

19.

Oktem E, Derle E, Kibaroglu S, Oktem C, Akkoyun I, Can U . The relationship between the degree of cognitive impairment and retinal nerve fiber layer thickness. Neurol Sci. 2015; 36(7):1141-6. DOI: 10.1007/s10072-014-2055-3. View

20.

Egana-Gorrono L, Lopez-Diez R, Yepuri G, Ramirez L, Reverdatto S, Gugger P . Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models. Front Cardiovasc Med. 2020; 7:37. PMC: 7076074. DOI: 10.3389/fcvm.2020.00037. View